首页 > 最新文献

Journal of Cardiovascular Electrophysiology最新文献

英文 中文
Thirty-day mortality risk in patients following radiofrequency and cryoballoon ablation for atrial fibrillation across the entire nation of Poland: An 8-year analysis from the National Health Fund of Poland. 波兰全国心房颤动射频和冷冻球囊消融术后患者的 30 天死亡风险:波兰国家卫生基金的 8 年分析。
IF 2.7 3区 医学 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-09-18 DOI: 10.1111/jce.16429
Michal Orczykowski,Marcin Kowalski,Valay K Parikh,Magdalena Topczewska,Piotr Urbanek,Bodalski Robert,Pawel Derejko,Andrzej Glowniak,Ewa Swierzynska-Wodarska,Maria Bilinska,Lukasz Szumowski
INTRODUCTIONAtrial fibrillation (AF) is the most common sustained arrhythmia, and catheter ablation (CA) is a primary therapeutic option. However, the 30-day all-cause mortality risk associated with CA for AF may be underestimated due to selection bias. Our study aimed to assess 30-day mortality in an unselected cohort of patients.METHODSData from the National Health Fund-Poland covered over 99% of nationwide radiofrequency ablation (RF) or cryoballoon ablation for AF, with 100% recorded deaths. The study included consecutive CA procedures in adult patients between 2012 and 2019. Thirty-day mortality rates were calculated for each age group.RESULTSA total of 31 214 CAs for AF were performed on 26 767 patients (34.8% female). Forty-four percent of patients had hypertension, 31.2% had coronary artery disease, 14.4% had heart failure, 11% had diabetes mellitus, 5.6% had malignant neoplasms, 2.7% had a previous myocardial infarction, 2.5% had a previous stroke, and 2.2% had kidney disease. Thirty-two deaths (0.1%) occurred within 30 days, with the highest mortality in the oldest age group (>80 years). Statistical analysis revealed higher incidences of kidney disease (p < 0.001) and heart failure (p = 0.001) in patients who died within 30 days. Mortality risk did not significantly differ between cryoballoon and RF ablation, as well as first and subsequent ablation for AF. The risk of death within 7 days postablation for AF was 1 in 2750 procedures, while the risk of death on the same day postablation was 1 in 6250 procedures.CONCLUSIONSThe 30-day mortality rate in a large, unselected AF ablation cohort, covering 99% of procedures in the country, is low except for the oldest patients. This factor should be taken into consideration when offering CA for AF.
导言 心房颤动(房颤)是最常见的持续性心律失常,导管消融(CA)是一种主要的治疗方法。然而,由于选择偏差,与心房颤动导管消融术相关的 30 天全因死亡率风险可能被低估。方法波兰国家卫生基金提供的数据涵盖了全国范围内 99% 以上的房颤射频消融(RF)或冷冻球囊消融术,其中 100% 有死亡记录。研究包括 2012 年至 2019 年间成年患者的连续 CA 手术。结果共为 26 767 名患者(34.8% 为女性)实施了 31 214 次房颤消融术。44%的患者患有高血压,31.2%患有冠状动脉疾病,14.4%患有心力衰竭,11%患有糖尿病,5.6%患有恶性肿瘤,2.7%曾患心肌梗死,2.5%曾患中风,2.2%患有肾脏疾病。有 32 例死亡病例(0.1%)发生在 30 天内,其中年龄最大(大于 80 岁)的患者死亡率最高。统计分析显示,30 天内死亡的患者中肾脏疾病(P < 0.001)和心力衰竭(P = 0.001)的发病率较高。低温球囊消融术和射频消融术以及房颤首次消融术和后续消融术之间的死亡风险没有明显差异。心房颤动消融术后 7 天内死亡的风险为每 2750 例手术中有 1 例死亡,而消融术后当天死亡的风险为每 6250 例手术中有 1 例死亡。在为房颤患者提供 CA 时应考虑到这一因素。
{"title":"Thirty-day mortality risk in patients following radiofrequency and cryoballoon ablation for atrial fibrillation across the entire nation of Poland: An 8-year analysis from the National Health Fund of Poland.","authors":"Michal Orczykowski,Marcin Kowalski,Valay K Parikh,Magdalena Topczewska,Piotr Urbanek,Bodalski Robert,Pawel Derejko,Andrzej Glowniak,Ewa Swierzynska-Wodarska,Maria Bilinska,Lukasz Szumowski","doi":"10.1111/jce.16429","DOIUrl":"https://doi.org/10.1111/jce.16429","url":null,"abstract":"INTRODUCTIONAtrial fibrillation (AF) is the most common sustained arrhythmia, and catheter ablation (CA) is a primary therapeutic option. However, the 30-day all-cause mortality risk associated with CA for AF may be underestimated due to selection bias. Our study aimed to assess 30-day mortality in an unselected cohort of patients.METHODSData from the National Health Fund-Poland covered over 99% of nationwide radiofrequency ablation (RF) or cryoballoon ablation for AF, with 100% recorded deaths. The study included consecutive CA procedures in adult patients between 2012 and 2019. Thirty-day mortality rates were calculated for each age group.RESULTSA total of 31 214 CAs for AF were performed on 26 767 patients (34.8% female). Forty-four percent of patients had hypertension, 31.2% had coronary artery disease, 14.4% had heart failure, 11% had diabetes mellitus, 5.6% had malignant neoplasms, 2.7% had a previous myocardial infarction, 2.5% had a previous stroke, and 2.2% had kidney disease. Thirty-two deaths (0.1%) occurred within 30 days, with the highest mortality in the oldest age group (>80 years). Statistical analysis revealed higher incidences of kidney disease (p < 0.001) and heart failure (p = 0.001) in patients who died within 30 days. Mortality risk did not significantly differ between cryoballoon and RF ablation, as well as first and subsequent ablation for AF. The risk of death within 7 days postablation for AF was 1 in 2750 procedures, while the risk of death on the same day postablation was 1 in 6250 procedures.CONCLUSIONSThe 30-day mortality rate in a large, unselected AF ablation cohort, covering 99% of procedures in the country, is low except for the oldest patients. This factor should be taken into consideration when offering CA for AF.","PeriodicalId":15178,"journal":{"name":"Journal of Cardiovascular Electrophysiology","volume":null,"pages":null},"PeriodicalIF":2.7,"publicationDate":"2024-09-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142267232","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cover Image, Volume 35, Issue 9 封面图片,第 35 卷第 9 期
IF 2.3 3区 医学 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-09-18 DOI: 10.1111/jce.16446
Leah A. John MD, MBA, Sanjay Divakaran MD, Ron Blankstein MD, Uyanga Batnyam MD, Pal Suranyi MD, PhD, Mathew Gregoski MS, PhD, Hubert Cochet MD, PhD, Jean-Marc Peyrat PhD, MBA, Nicolas Cedlink PhD, Luis Kabongo PhD, Bruno Soré BSc, Joseph Schoepf MD, William H. Sauer MD, Jeffrey R. Winterfield MD, Usha B. Tedrow MD, MSc

The cover image is based on the Article Septal late enhancement by cardiac CT is associated with repeat ablation in nonischemic cardiomyopathy patients by Leah A. John et al., https://doi.org/10.1111/jce.16356

封面图片来自 Leah A. John 等人撰写的文章《心脏 CT 的室间隔晚期增强与非缺血性心肌病患者重复消融相关》,https://doi.org/10.1111/jce.16356。
{"title":"Cover Image, Volume 35, Issue 9","authors":"Leah A. John MD, MBA,&nbsp;Sanjay Divakaran MD,&nbsp;Ron Blankstein MD,&nbsp;Uyanga Batnyam MD,&nbsp;Pal Suranyi MD, PhD,&nbsp;Mathew Gregoski MS, PhD,&nbsp;Hubert Cochet MD, PhD,&nbsp;Jean-Marc Peyrat PhD, MBA,&nbsp;Nicolas Cedlink PhD,&nbsp;Luis Kabongo PhD,&nbsp;Bruno Soré BSc,&nbsp;Joseph Schoepf MD,&nbsp;William H. Sauer MD,&nbsp;Jeffrey R. Winterfield MD,&nbsp;Usha B. Tedrow MD, MSc","doi":"10.1111/jce.16446","DOIUrl":"https://doi.org/10.1111/jce.16446","url":null,"abstract":"<p>The cover image is based on the Article <i>Septal late enhancement by cardiac CT is associated with repeat ablation in nonischemic cardiomyopathy patients</i> by Leah A. John et al., https://doi.org/10.1111/jce.16356\u0000 \u0000 <figure>\u0000 <div><picture>\u0000 <source></source></picture><p></p>\u0000 </div>\u0000 </figure></p>","PeriodicalId":15178,"journal":{"name":"Journal of Cardiovascular Electrophysiology","volume":null,"pages":null},"PeriodicalIF":2.3,"publicationDate":"2024-09-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/jce.16446","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142245086","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Spontaneous termination of ventricular tachycardia in the human heart. 人体心脏室性心动过速的自发终止。
IF 2.3 3区 医学 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-09-16 DOI: 10.1111/jce.16421
Takahiro Hayashi, Nathan Denham, Chloe Nettlefold, Jayant Kakarla, Robert Anderson, Abhishek Bhaskaran, Stéphane Massé, Eugene Downar, Kumaraswamy Nanthakumar

Introduction: Understanding the spatiotemporal location of the spontaneous termination of ventricular tachycardia (VT) may provide new insights for ablation. To test the hypothesis that spontaneous VT termination most frequently occurs at the VT exit due to source-sink mismatch and to characterize electrophysiological properties of the sites termination during VT and with extra-stimulus technique.

Methods: Retrospective analysis of intraoperative mapping studies of nine patients with ischemic cardiopathy or repaired tetralogy of Fallot. Simultaneous endocardial and epicardial mapping was performed in both ventricles using a custom mapping array during VT. Electrogram (EGM) characteristics before and at the moment of termination were analyzed including: cycle length oscillations, EGM heterogeneity and a variation in the systolic/diastolic path. The decrements to extra stimulus were analysed for termination sites and other diastolic sites.

Results: Nine VTs in seven patients demonstrated spontaneous VT termination. Seven VTs (77.8%) spontaneously terminated in the final third of the systolic interval, one (11.1%) in early diastole and one (11.1%) in mid diastole. Cycle length oscillations (prolongation, shortening, and no change) were seen in equal frequency. Four VTs (44.4%) showed alternans in the local EGM at the site of termination and this was more prevalent than alternans at other sites in the diastolic pathway (p < .001). Only one-third of VTs showed a change in activation pattern before termination. There was no difference based on etiology. During substrate characterization with extra-stimulus pacing, sites of spontaneous termination showed greater decrement than other sites of the VT circuit during pacing (43.5 ± 14.5 ms vs. 31.2 ± 31.2 ms; p = .003).

Conclusion: The entrance zone rather than the exit is the commonest site for the spontaneous termination of VT in the human heart. These sites tend to demonstrate EGM alternans during VT and greater decrement during extrastimulus pacing. These findings may help guide future studies into improving the success of VT ablation.

简介:了解室性心动过速(VT)自发终止的时空位置可为消融提供新的见解。为了验证室性心动过速自发终止最常发生在室性心动过速出口处是由于源-汇不匹配造成的这一假说,并描述室性心动过速时终止部位的电生理特性以及外部刺激技术:方法:对九名缺血性心脏病或法洛氏四联症修复患者的术中绘图研究进行回顾性分析。在 VT 时使用定制的映射阵列在两个心室同时进行心内膜和心外膜映射。分析了终止前和终止时的电图(EGM)特征,包括:周期长度振荡、EGM异质性和收缩/舒张路径的变化。分析了终止部位和其他舒张部位对额外刺激的减弱情况:结果:7 名患者的 9 个 VT 均表现为自发性 VT 终止。7个VT(77.8%)自发终止于收缩间期的最后1/3,1个(11.1%)终止于舒张早期,1个(11.1%)终止于舒张中期。周期长度振荡(延长、缩短和无变化)出现的频率相同。四例 VT(44.4%)在终止部位的局部 EGM 中出现交替,这种情况比舒张途径中其他部位的交替更为普遍(P 结 论):在人体心脏中,VT 自发终止的最常见部位是入口区而非出口区。这些部位往往在 VT 期间表现出 EGM 交替,并在刺激外起搏期间表现出更大的衰减。这些发现可能有助于指导未来提高 VT 消融成功率的研究。
{"title":"Spontaneous termination of ventricular tachycardia in the human heart.","authors":"Takahiro Hayashi, Nathan Denham, Chloe Nettlefold, Jayant Kakarla, Robert Anderson, Abhishek Bhaskaran, Stéphane Massé, Eugene Downar, Kumaraswamy Nanthakumar","doi":"10.1111/jce.16421","DOIUrl":"https://doi.org/10.1111/jce.16421","url":null,"abstract":"<p><strong>Introduction: </strong>Understanding the spatiotemporal location of the spontaneous termination of ventricular tachycardia (VT) may provide new insights for ablation. To test the hypothesis that spontaneous VT termination most frequently occurs at the VT exit due to source-sink mismatch and to characterize electrophysiological properties of the sites termination during VT and with extra-stimulus technique.</p><p><strong>Methods: </strong>Retrospective analysis of intraoperative mapping studies of nine patients with ischemic cardiopathy or repaired tetralogy of Fallot. Simultaneous endocardial and epicardial mapping was performed in both ventricles using a custom mapping array during VT. Electrogram (EGM) characteristics before and at the moment of termination were analyzed including: cycle length oscillations, EGM heterogeneity and a variation in the systolic/diastolic path. The decrements to extra stimulus were analysed for termination sites and other diastolic sites.</p><p><strong>Results: </strong>Nine VTs in seven patients demonstrated spontaneous VT termination. Seven VTs (77.8%) spontaneously terminated in the final third of the systolic interval, one (11.1%) in early diastole and one (11.1%) in mid diastole. Cycle length oscillations (prolongation, shortening, and no change) were seen in equal frequency. Four VTs (44.4%) showed alternans in the local EGM at the site of termination and this was more prevalent than alternans at other sites in the diastolic pathway (p < .001). Only one-third of VTs showed a change in activation pattern before termination. There was no difference based on etiology. During substrate characterization with extra-stimulus pacing, sites of spontaneous termination showed greater decrement than other sites of the VT circuit during pacing (43.5 ± 14.5 ms vs. 31.2 ± 31.2 ms; p = .003).</p><p><strong>Conclusion: </strong>The entrance zone rather than the exit is the commonest site for the spontaneous termination of VT in the human heart. These sites tend to demonstrate EGM alternans during VT and greater decrement during extrastimulus pacing. These findings may help guide future studies into improving the success of VT ablation.</p>","PeriodicalId":15178,"journal":{"name":"Journal of Cardiovascular Electrophysiology","volume":null,"pages":null},"PeriodicalIF":2.3,"publicationDate":"2024-09-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142288022","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Decremental properties of a concealed nodoventricular pathway 隐蔽结节心室通路的递减特性
IF 2.7 3区 医学 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-09-11 DOI: 10.1111/jce.16430
Koumei Onuki, Koichi Nagashima, Yasuharu Matsunaga‐Lee, Masato Fukunaga, Kenichi Hiroshima, Kenji Ando, Melvin M. Scheinman
IntroductionThe decremental properties of the nodoventricular pathway (NVP) are uncertain.Methods and ResultsDuring short RP supraventricular tachycardia, a His‐refractory premature ventricular contraction (PVC) consistently terminated the tachycardia without atrial capture immediately after the PVC. Whereas a slightly earlier PVC failed to reset the subsequent His but terminated the tachycardia without atrial capture one cycle later.ConclusionThese observations are diagnostic of slow‐fast atrioventricular nodal reentrant tachycardia (AVNRT) with a bystander concealed‐NVP and can be explained by decremental properties in the NVP itself; greater prematurity of the PVC resulted in more decremental conduction over the NVP, causing the AVNRT termination one cycle later.
方法和结果在短程 RP 室上性心动过速中,His 难复性室性早搏收缩(PVC)持续终止心动过速,且在 PVC 结束后未立即捕获心房。结论这些观察结果可诊断为慢速房室结复律性心动过速(AVNRT),并伴有旁观者隐匿性室性早搏,其原因可以用室性早搏本身的递减特性来解释;室性早搏的过早发生导致室性早搏的递减传导增加,从而导致 AVNRT 在一个周期后终止。
{"title":"Decremental properties of a concealed nodoventricular pathway","authors":"Koumei Onuki, Koichi Nagashima, Yasuharu Matsunaga‐Lee, Masato Fukunaga, Kenichi Hiroshima, Kenji Ando, Melvin M. Scheinman","doi":"10.1111/jce.16430","DOIUrl":"https://doi.org/10.1111/jce.16430","url":null,"abstract":"IntroductionThe decremental properties of the nodoventricular pathway (NVP) are uncertain.Methods and ResultsDuring short RP supraventricular tachycardia, a His‐refractory premature ventricular contraction (PVC) consistently terminated the tachycardia without atrial capture immediately after the PVC. Whereas a slightly earlier PVC failed to reset the subsequent His but terminated the tachycardia without atrial capture one cycle later.ConclusionThese observations are diagnostic of slow‐fast atrioventricular nodal reentrant tachycardia (AVNRT) with a bystander concealed‐NVP and can be explained by decremental properties in the NVP itself; greater prematurity of the PVC resulted in more decremental conduction over the NVP, causing the AVNRT termination one cycle later.","PeriodicalId":15178,"journal":{"name":"Journal of Cardiovascular Electrophysiology","volume":null,"pages":null},"PeriodicalIF":2.7,"publicationDate":"2024-09-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142181524","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
His‐bundle pacing from the right atrium: Solving pacemaker implantation challenges post‐TriClip 右心房 His-bundle 起搏:解决三夹式起搏器植入术后的难题
IF 2.7 3区 医学 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-09-11 DOI: 10.1111/jce.16431
Yoshimi Onishi, Alberto Barengo, Francesco Fioravanti, Lorenzo Rampa, Gabriele Paglino, Paolo Della Bella
IntroductionThis case report highlights the novel role of His‐bundle pacing (HBP) from right atrium, not just for preserving cardiac function, but also for avoiding interference with TriClip devices.Methods and ResultsA 78‐year‐old female with severe tricuspid regurgitation received two TriClip devices. Postprocedure, frequent significant sinus pauses required a pacemaker. HBP was chosen to avoid lead complications. Under local anesthesia, a His pacing lead was inserted via the axillary vein using specialized catheter. Follow‐ups over 2.5 years showed stable parameters with no complications.ConclusionHBP is effective for patients with TriClip devices, ensuring optimal cardiac function and lead stability.
导言本病例报告强调了从右心房进行 His-bundle 起搏(HBP)的新作用,它不仅能保护心脏功能,还能避免与 TriClip 装置发生干扰。术后经常出现明显的窦性停搏,需要安装起搏器。为了避免导联并发症,她选择了 HBP。在局部麻醉下,使用专用导管通过腋静脉插入 His 起搏导联。结论 HBP 对使用 TriClip 装置的患者很有效,能确保最佳的心脏功能和导联稳定性。
{"title":"His‐bundle pacing from the right atrium: Solving pacemaker implantation challenges post‐TriClip","authors":"Yoshimi Onishi, Alberto Barengo, Francesco Fioravanti, Lorenzo Rampa, Gabriele Paglino, Paolo Della Bella","doi":"10.1111/jce.16431","DOIUrl":"https://doi.org/10.1111/jce.16431","url":null,"abstract":"IntroductionThis case report highlights the novel role of His‐bundle pacing (HBP) from right atrium, not just for preserving cardiac function, but also for avoiding interference with TriClip devices.Methods and ResultsA 78‐year‐old female with severe tricuspid regurgitation received two TriClip devices. Postprocedure, frequent significant sinus pauses required a pacemaker. HBP was chosen to avoid lead complications. Under local anesthesia, a His pacing lead was inserted via the axillary vein using specialized catheter. Follow‐ups over 2.5 years showed stable parameters with no complications.ConclusionHBP is effective for patients with TriClip devices, ensuring optimal cardiac function and lead stability.","PeriodicalId":15178,"journal":{"name":"Journal of Cardiovascular Electrophysiology","volume":null,"pages":null},"PeriodicalIF":2.7,"publicationDate":"2024-09-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142181526","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Methodological issues on AV‐optimized conduction system pacing for treatment of AV dromotropathy: A randomized, cross‐over study 治疗房室传导障碍的房室优化传导系统起搏的方法问题:随机交叉研究
IF 2.7 3区 医学 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-09-10 DOI: 10.1111/jce.16427
Mojtaba Soltani‐Kermanshahi
{"title":"Methodological issues on AV‐optimized conduction system pacing for treatment of AV dromotropathy: A randomized, cross‐over study","authors":"Mojtaba Soltani‐Kermanshahi","doi":"10.1111/jce.16427","DOIUrl":"https://doi.org/10.1111/jce.16427","url":null,"abstract":"","PeriodicalId":15178,"journal":{"name":"Journal of Cardiovascular Electrophysiology","volume":null,"pages":null},"PeriodicalIF":2.7,"publicationDate":"2024-09-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142181558","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Real‐world battery longevity of implantable loop recorders implanted for unexplained syncope: Results from a large single‐center registry 因不明原因晕厥而植入的植入式回路记录器的实际电池寿命:大型单中心登记的结果
IF 2.7 3区 医学 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-09-10 DOI: 10.1111/jce.16420
Lukas Duvillier, Anthony Demolder, Sally Van Renterghem, Caroline De Mey, Filip West, Jan De Pooter
Background/PurposeImplantable loop recorders (ILR) are increasingly used in cardiac rhythm monitoring and diagnostic work‐up of unexplained syncope. ILR battery longevity, according to manufacturers' product performance specifications, typically ranges between 2 and 4 years, but real‐world data in this population are lacking.MethodsThis monocentric, prospective, observational study included consecutive patients with unexplained syncope undergoing ILR implantation between October 2007 and 2019. The main purpose was to determine real‐world battery longevity of ILRs. Diagnostic yield and relationship between arrhythmogenic diagnosis and duration of ILR monitoring were explored.ResultsThe study included 309 patients (59 years [38–73], 49% female) with ILR implantation for unexplained syncope. Median battery longevity was 42 [40–45] months. A total of 99.5% of ILRs reached prespecified battery longevity. The time to end‐of‐life varied by up to 33 months among the same ILR models. Overall arrhythmogenic diagnostic yield counted 27% (73% sick sinus syndrome, 20% atrioventricular block, and 7% ventricular tachycardia). Median time to diagnosis was 10 [2–25] months, with the latest event at 43 months. The cumulative diagnostic yield for arrhythmogenic event explaining syncope was 4.2%, 6.1%, 9.4%, 14.6%, 19.4%, and 26.7% at 1, 2, 6, 12, 24, and 48 months, respectively. In univariate analysis, first degree AV block and prolonged HV time on EP study were predictors of diagnosis, while QRS duration abnormality borderline missed significance.ConclusionsReal‐world battery longevity of ILRs matched industry projected longevity in 99.5% of patients implanted with ILR for unexplained syncope. A battery longevity of minimum 3.5 years is recommended to maximize the diagnostic yield in this population.
背景/目的植入式回路记录器(ILR)越来越多地用于心律监测和不明原因晕厥的诊断工作。根据制造商的产品性能说明,ILR 的电池寿命通常在 2 到 4 年之间,但缺乏该人群的实际数据。方法这项单中心、前瞻性、观察性研究纳入了 2007 年 10 月至 2019 年期间接受 ILR 植入术的不明原因晕厥连续患者。主要目的是确定ILR在真实世界中的电池寿命。结果该研究纳入了 309 名因不明原因晕厥而接受 ILR 植入术的患者(59 岁 [38-73],49% 为女性)。中位电池寿命为 42 [40-45] 个月。99.5%的ILR达到了预设的电池寿命。同一型号的ILR寿命终止时间最多相差33个月。总体心律失常诊断率为 27%(病窦综合征 73%、房室传导阻滞 20%、室性心动过速 7%)。诊断的中位时间为 10 [2-25] 个月,最近一次诊断为 43 个月。在 1、2、6、12、24 和 48 个月时,解释晕厥的致心律失常事件的累积诊断率分别为 4.2%、6.1%、9.4%、14.6%、19.4% 和 26.7%。在单变量分析中,EP 研究中的一级房室传导阻滞和 HV 时间延长是诊断的预测因素,而 QRS 持续时间异常则未达到显著性水平。建议电池寿命至少为 3.5 年,以最大限度地提高这类人群的诊断率。
{"title":"Real‐world battery longevity of implantable loop recorders implanted for unexplained syncope: Results from a large single‐center registry","authors":"Lukas Duvillier, Anthony Demolder, Sally Van Renterghem, Caroline De Mey, Filip West, Jan De Pooter","doi":"10.1111/jce.16420","DOIUrl":"https://doi.org/10.1111/jce.16420","url":null,"abstract":"Background/PurposeImplantable loop recorders (ILR) are increasingly used in cardiac rhythm monitoring and diagnostic work‐up of unexplained syncope. ILR battery longevity, according to manufacturers' product performance specifications, typically ranges between 2 and 4 years, but real‐world data in this population are lacking.MethodsThis monocentric, prospective, observational study included consecutive patients with unexplained syncope undergoing ILR implantation between October 2007 and 2019. The main purpose was to determine real‐world battery longevity of ILRs. Diagnostic yield and relationship between arrhythmogenic diagnosis and duration of ILR monitoring were explored.ResultsThe study included 309 patients (59 years [38–73], 49% female) with ILR implantation for unexplained syncope. Median battery longevity was 42 [40–45] months. A total of 99.5% of ILRs reached prespecified battery longevity. The time to end‐of‐life varied by up to 33 months among the same ILR models. Overall arrhythmogenic diagnostic yield counted 27% (73% sick sinus syndrome, 20% atrioventricular block, and 7% ventricular tachycardia). Median time to diagnosis was 10 [2–25] months, with the latest event at 43 months. The cumulative diagnostic yield for arrhythmogenic event explaining syncope was 4.2%, 6.1%, 9.4%, 14.6%, 19.4%, and 26.7% at 1, 2, 6, 12, 24, and 48 months, respectively. In univariate analysis, first degree AV block and prolonged HV time on EP study were predictors of diagnosis, while QRS duration abnormality borderline missed significance.ConclusionsReal‐world battery longevity of ILRs matched industry projected longevity in 99.5% of patients implanted with ILR for unexplained syncope. A battery longevity of minimum 3.5 years is recommended to maximize the diagnostic yield in this population.","PeriodicalId":15178,"journal":{"name":"Journal of Cardiovascular Electrophysiology","volume":null,"pages":null},"PeriodicalIF":2.7,"publicationDate":"2024-09-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142181557","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Combined approach of high‐power and very high‐power, short‐duration ablation in superior vena cava isolation 上腔静脉隔绝术中的大功率和超大功率短时消融联合方法
IF 2.7 3区 医学 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-09-10 DOI: 10.1111/jce.16424
Toshio Makita, Taishi Kuwahara, Kenta Takahashi, Takuya Oshio, Kenta Kadono, Yoshimi Oyagi, Yayoi Ito, Ryo Takahashi
IntroductionThe effectiveness and safety of 50 W, high‐power, short‐duration (HPSD) ablation in superior vena cava isolation (SVCI) for patients with atrial fibrillation (AF) have been reported. However, the acute outcomes of SVCI combined with 90 W/4 s, very high‐power, short‐duration (vHPSD) ablation remain unknown. In this study, we aimed to investigate a novel approach that combines 50 W‐HPSD and 90 W/4 s‐vHPSD ablation in SVCI and to elucidate the characteristics, outcomes, and safety of this approach by comparing SVCI with conventional ablation index (AI)‐guided middle‐power, middle‐duration (MPMD) ablation.MethodsOverall, 126 patients who underwent AF ablation with SVCI using the QDOT MICROTM catheter were retrospectively reviewed; one group underwent SVCI with a combined approach of HPSD and vHPSD ablation (50 W/90 W group, n = 73) and another group underwent AI‐guided MPMD ablation (30–40 W group, n = 53). This study compared the procedural details, radiofrequency (RF) ablation profiles, and complications. The RF settings used in the 50 W/90 W group were 50 W/7 s for the lateral segment close to the phrenic nerve and 90 W/4 s for the nonlateral segment.ResultsThe 50 W/90 W group required a significantly shorter procedural time (3.2 vs. 5.9 min, p < .001), shorter RF duration (42.0 vs. 162.0 s, p < .001), and lower RF energy (2834 vs. 5480 J, p < .001) than the 30–40 W group. Procedural success, first‐pass SVCI, number of RF applications, and SVC reconnection after isoproterenol loading were comparable between the groups. The maximum tip‐electrode temperature of the multi‐thermocouple system was significantly higher in the 50 W/90 W group than in the 30–40 W group (50.0°C vs. 47.0°C, p < .001). No complications, such as phrenic nerve injury or bleeding requiring transfusion, were observed in either group.ConclusionsThe combined approach of 50 W/7 s‐HPSD and 90 W/4 s‐vHPSD ablation resulted in successful and safe SVCI with shorter procedural time, shorter RF duration, and lower RF energy.
导言已有报道称,上腔静脉隔绝术(SVCI)中 50 瓦、高功率、短持续时间(HPSD)消融术对心房颤动(AF)患者的有效性和安全性。然而,SVCI 联合 90 瓦/4 秒、超高功率、短持续时间(vHPSD)消融术的急性疗效仍不得而知。在这项研究中,我们旨在研究一种在 SVCI 中结合 50 W-HPSD 和 90 W/4 s-vHPSD 消融的新方法,并通过比较 SVCI 和传统消融指数(AI)引导的中功率、中持续时间(MPMD)消融,阐明这种方法的特点、结果和安全性。方法回顾性研究了使用 QDOT MICROTM 导管以 SVCI 进行房颤消融的 126 例患者,其中一组患者以 HPSD 和 vHPSD 消融联合方法接受了 SVCI(50 W/90 W 组,n = 73),另一组患者接受了 AI 引导的 MPMD 消融(30-40 W 组,n = 53)。本研究比较了手术细节、射频 (RF) 消融概况和并发症。结果与 30-40 W 组相比,50 W/90 W 组所需的手术时间显著缩短(3.2 分钟对 5.9 分钟,p < .001),射频持续时间显著缩短(42.0 秒对 162.0 秒,p < .001),射频能量显著降低(2834 焦耳对 5480 焦耳,p < .001)。两组的手术成功率、首次 SVCI、射频应用次数和异丙托品醇加载后的 SVC 再连接情况相当。50 瓦/90 瓦组的多热电偶系统尖端电极最高温度明显高于 30-40 瓦组(50.0°C vs. 47.0°C,p < .001)。结论 50 W/7 s-HPSD 和 90 W/4 s-vHPSD 消融联合方法可成功、安全地进行 SVCI,且手术时间更短、射频持续时间更短、射频能量更低。
{"title":"Combined approach of high‐power and very high‐power, short‐duration ablation in superior vena cava isolation","authors":"Toshio Makita, Taishi Kuwahara, Kenta Takahashi, Takuya Oshio, Kenta Kadono, Yoshimi Oyagi, Yayoi Ito, Ryo Takahashi","doi":"10.1111/jce.16424","DOIUrl":"https://doi.org/10.1111/jce.16424","url":null,"abstract":"IntroductionThe effectiveness and safety of 50 W, high‐power, short‐duration (HPSD) ablation in superior vena cava isolation (SVCI) for patients with atrial fibrillation (AF) have been reported. However, the acute outcomes of SVCI combined with 90 W/4 s, very high‐power, short‐duration (vHPSD) ablation remain unknown. In this study, we aimed to investigate a novel approach that combines 50 W‐HPSD and 90 W/4 s‐vHPSD ablation in SVCI and to elucidate the characteristics, outcomes, and safety of this approach by comparing SVCI with conventional ablation index (AI)‐guided middle‐power, middle‐duration (MPMD) ablation.MethodsOverall, 126 patients who underwent AF ablation with SVCI using the QDOT MICRO<jats:sup>TM</jats:sup> catheter were retrospectively reviewed; one group underwent SVCI with a combined approach of HPSD and vHPSD ablation (50 W/90 W group, <jats:italic>n</jats:italic> = 73) and another group underwent AI‐guided MPMD ablation (30–40 W group, <jats:italic>n</jats:italic> = 53). This study compared the procedural details, radiofrequency (RF) ablation profiles, and complications. The RF settings used in the 50 W/90 W group were 50 W/7 s for the lateral segment close to the phrenic nerve and 90 W/4 s for the nonlateral segment.ResultsThe 50 W/90 W group required a significantly shorter procedural time (3.2 vs. 5.9 min, <jats:italic>p</jats:italic> &lt; .001), shorter RF duration (42.0 vs. 162.0 s, <jats:italic>p</jats:italic> &lt; .001), and lower RF energy (2834 vs. 5480 J, <jats:italic>p</jats:italic> &lt; .001) than the 30–40 W group. Procedural success, first‐pass SVCI, number of RF applications, and SVC reconnection after isoproterenol loading were comparable between the groups. The maximum tip‐electrode temperature of the multi‐thermocouple system was significantly higher in the 50 W/90 W group than in the 30–40 W group (50.0°C vs. 47.0°C, <jats:italic>p</jats:italic> &lt; .001). No complications, such as phrenic nerve injury or bleeding requiring transfusion, were observed in either group.ConclusionsThe combined approach of 50 W/7 s‐HPSD and 90 W/4 s‐vHPSD ablation resulted in successful and safe SVCI with shorter procedural time, shorter RF duration, and lower RF energy.","PeriodicalId":15178,"journal":{"name":"Journal of Cardiovascular Electrophysiology","volume":null,"pages":null},"PeriodicalIF":2.7,"publicationDate":"2024-09-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142181527","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Left ventricular volumes and function in successful and failed His‐BundLe Pacing. A comparative prospective study 成功和失败的 His-BundLe 起搏的左心室容量和功能。前瞻性对比研究
IF 2.7 3区 医学 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-09-10 DOI: 10.1111/jce.16426
Francesco Notaristefano, Alberto Barengo, Lorenzo Spighi, Silvia Piraccini, Manuel Freschini, Stefano Sforna, Federica Pesce, Giuseppe Giuffrè, Alessandra Bagnacani, Matteo D'Ammando, Gianluca Zingarini, Salvatore Notaristefano, Claudio Cavallini, Paolo Verdecchia, Rocco Sclafani, Fabio Angeli
IntroductionInitial data suggest that His Bundle Pacing (HBP) could preserve long‐term cardiac structure and function better than Right Ventricular Pacing (RVP), but evidence is limited.MethodsWe studied consecutive patients with baseline ejection fraction (EF) ≥ 50% who underwent HBP attempt, either successful (HBP group) or failed (RVP group). Two‐dimensional (2D) and three‐dimensional (3D) echocardiography were carried out at baseline and after 6 months of ventricular pacing burden > 20%.ResultsAmong 68 patients, 40 underwent successful HBP, and 28 RVP. The HBP and RVP groups did not differ for age, sex and pacing indication. At baseline, the HBP and RVP groups did not differ for 2D EF (62% vs. 62%), 3D EF (60% vs. 63%), 2D (−19% vs. −19%) and 3D global longitudinal strain (GLS) (−15% vs. −16%). After 6 months, 2D EF (−3.86%) and 3D EF (−5.71%) significantly decreased in the RVP group and did not change in the HBP group (p for interaction .006 and <.001, respectively). 2D GLS (3.08%) and 3D GLS (2.22%) significantly increased in the RVP group, but did not change in the HBP group (p for interaction .013 and <.016, respectively). Pacing induced cardiomyopathy (PICM) (EF drop ≥ 10% and EF < 50%) occurred in 14% (RVP) versus 0% (HBP) of patients (p = .025).ConclusionsSuccessful HBP was superior to RVP in preserving LV systolic function despite a high ventricular pacing burden, and was less frequently associated with PICM.
方法我们对基线射血分数(EF)≥50%、尝试 HBP 成功(HBP 组)或失败(RVP 组)的连续患者进行了研究。在基线和心室起搏负担> 20%的6个月后进行了二维(2D)和三维(3D)超声心动图检查。结果68名患者中,40人成功进行了HBP,28人进行了RVP。HBP 组和 RVP 组在年龄、性别和起搏适应症方面没有差异。基线时,HBP 组和 RVP 组在 2D EF(62% 对 62%)、3D EF(60% 对 63%)、2D(-19% 对 -19%)和 3D 全局纵向应变(GLS)(-15% 对 -16%)方面没有差异。6 个月后,RVP 组的二维 EF(-3.86%)和三维 EF(-5.71%)显著下降,而 HBP 组没有变化(交互作用 p 分别为 .006 和 <.001)。二维 GLS(3.08%)和三维 GLS(2.22%)在 RVP 组明显增加,但在 HBP 组没有变化(交互作用的 p 分别为 .013 和 <.016)。14%(RVP)和 0%(HBP)的患者发生了起搏诱发的心肌病(PICM)(EF 下降≥ 10% 和 EF <50%)(P = .025)。
{"title":"Left ventricular volumes and function in successful and failed His‐BundLe Pacing. A comparative prospective study","authors":"Francesco Notaristefano, Alberto Barengo, Lorenzo Spighi, Silvia Piraccini, Manuel Freschini, Stefano Sforna, Federica Pesce, Giuseppe Giuffrè, Alessandra Bagnacani, Matteo D'Ammando, Gianluca Zingarini, Salvatore Notaristefano, Claudio Cavallini, Paolo Verdecchia, Rocco Sclafani, Fabio Angeli","doi":"10.1111/jce.16426","DOIUrl":"https://doi.org/10.1111/jce.16426","url":null,"abstract":"IntroductionInitial data suggest that His Bundle Pacing (HBP) could preserve long‐term cardiac structure and function better than Right Ventricular Pacing (RVP), but evidence is limited.MethodsWe studied consecutive patients with baseline ejection fraction (EF) ≥ 50% who underwent HBP attempt, either successful (HBP group) or failed (RVP group). Two‐dimensional (2D) and three‐dimensional (3D) echocardiography were carried out at baseline and after 6 months of ventricular pacing burden &gt; 20%.ResultsAmong 68 patients, 40 underwent successful HBP, and 28 RVP. The HBP and RVP groups did not differ for age, sex and pacing indication. At baseline, the HBP and RVP groups did not differ for 2D EF (62% vs. 62%), 3D EF (60% vs. 63%), 2D (−19% vs. −19%) and 3D global longitudinal strain (GLS) (−15% vs. −16%). After 6 months, 2D EF (−3.86%) and 3D EF (−5.71%) significantly decreased in the RVP group and did not change in the HBP group (<jats:italic>p</jats:italic> for interaction .006 and &lt;.001, respectively). 2D GLS (3.08%) and 3D GLS (2.22%) significantly increased in the RVP group, but did not change in the HBP group (<jats:italic>p</jats:italic> for interaction .013 and &lt;.016, respectively). Pacing induced cardiomyopathy (PICM) (EF drop ≥ 10% and EF &lt; 50%) occurred in 14% (RVP) versus 0% (HBP) of patients (<jats:italic>p</jats:italic> = .025).ConclusionsSuccessful HBP was superior to RVP in preserving LV systolic function despite a high ventricular pacing burden, and was less frequently associated with PICM.","PeriodicalId":15178,"journal":{"name":"Journal of Cardiovascular Electrophysiology","volume":null,"pages":null},"PeriodicalIF":2.7,"publicationDate":"2024-09-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142181559","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Indications and outcomes of elective open chest lead extractions. 选择性开胸引线拔除术的适应症和结果。
IF 2.3 3区 医学 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-09-05 DOI: 10.1111/jce.16412
Anshul R Gupta, John R Power, Yang Yang, Travis Pollema, Arman Arghami, Ulrika Birgersdotter-Green, Yong-Mei Cha

Background: Complications associated with cardiovascular implantable electronic devices may necessitate device and lead removal. An open approach to removal may be electively chosen in cases with high risk of complications or those requiring additional concomitant cardiac surgery. This study aimed to investigate outcomes of patients who underwent elective open lead extractions (OLE) at two large tertiary care centers.

Methods: The records of 29 patients undergoing elective OLE were analyzed through retrospective chart review.

Results: 69 total leads were extracted from 29 patients (77% completely, 23% partially). The average age of the oldest leads was 13.3 ± 11.3 years. Infective endocarditis with severe valvular insufficiency requiring valvular intervention (41%)-an infectious etiology, and tricuspid valve intervention to correct RV lead-related severe TR (38%)-a noninfectious etiology, were the most common reasons for OLE. 38% of the patients had additional co-primary or secondary indications for open extraction, such as CABG and pericardiectomies. The rate of major complications and procedural failure was 3% each (1/29). 30-day survival was 100%, and 1-year survival was 92%. The average length of hospital stay was 15 days and higher among those undergoing OLE for infectious indications.

Conclusion: Open lead extractions offered a similar clinical success rate (97%) to transvenous extractions in this cohort and may be a viable alternative for those necessitating valvular intervention or when the risk of complications from TLE is considered very high.

背景:与心血管植入式电子设备相关的并发症可能会导致设备和导线的移除。对于并发症风险较高或需要同时进行心脏手术的病例,可选择开放式方法取出。本研究旨在调查两家大型三级医疗中心接受择期开放式导联取出术(OLE)患者的治疗效果:方法:通过回顾性病历分析了 29 名接受择期开放导联取出术的患者的病历:结果:29 名患者共抽取了 69 条导联(77% 完全抽取,23% 部分抽取)。最老导联的平均年龄为(13.3 ± 11.3)岁。感染性心内膜炎伴严重瓣膜功能不全需要瓣膜介入治疗(41%)--感染性病因,以及三尖瓣介入治疗以纠正 RV 导联相关的严重 TR(38%)--非感染性病因,是 OLE 最常见的原因。38%的患者还有其他首要或次要的开放摘除指征,如心血管造影术和心包切除术。主要并发症和手术失败率各为3%(1/29)。30天存活率为100%,1年存活率为92%。平均住院时间为15天,因感染原因接受OLE的患者平均住院时间更长:结论:在这批患者中,开放式导联取出术的临床成功率(97%)与经静脉导联取出术相似,对于需要进行瓣膜介入治疗或认为经静脉导联取出术并发症风险很高的患者来说,开放式导联取出术可能是一种可行的替代方法。
{"title":"Indications and outcomes of elective open chest lead extractions.","authors":"Anshul R Gupta, John R Power, Yang Yang, Travis Pollema, Arman Arghami, Ulrika Birgersdotter-Green, Yong-Mei Cha","doi":"10.1111/jce.16412","DOIUrl":"https://doi.org/10.1111/jce.16412","url":null,"abstract":"<p><strong>Background: </strong>Complications associated with cardiovascular implantable electronic devices may necessitate device and lead removal. An open approach to removal may be electively chosen in cases with high risk of complications or those requiring additional concomitant cardiac surgery. This study aimed to investigate outcomes of patients who underwent elective open lead extractions (OLE) at two large tertiary care centers.</p><p><strong>Methods: </strong>The records of 29 patients undergoing elective OLE were analyzed through retrospective chart review.</p><p><strong>Results: </strong>69 total leads were extracted from 29 patients (77% completely, 23% partially). The average age of the oldest leads was 13.3 ± 11.3 years. Infective endocarditis with severe valvular insufficiency requiring valvular intervention (41%)-an infectious etiology, and tricuspid valve intervention to correct RV lead-related severe TR (38%)-a noninfectious etiology, were the most common reasons for OLE. 38% of the patients had additional co-primary or secondary indications for open extraction, such as CABG and pericardiectomies. The rate of major complications and procedural failure was 3% each (1/29). 30-day survival was 100%, and 1-year survival was 92%. The average length of hospital stay was 15 days and higher among those undergoing OLE for infectious indications.</p><p><strong>Conclusion: </strong>Open lead extractions offered a similar clinical success rate (97%) to transvenous extractions in this cohort and may be a viable alternative for those necessitating valvular intervention or when the risk of complications from TLE is considered very high.</p>","PeriodicalId":15178,"journal":{"name":"Journal of Cardiovascular Electrophysiology","volume":null,"pages":null},"PeriodicalIF":2.3,"publicationDate":"2024-09-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142140200","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of Cardiovascular Electrophysiology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1